Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 147

1.
2.

A role for triggering receptor expressed on myeloid cells-1 in host defense during the early-induced and adaptive phases of the immune response.

Bleharski JR, Kiessler V, Buonsanti C, Sieling PA, Stenger S, Colonna M, Modlin RL.

J Immunol. 2003 Apr 1;170(7):3812-8.

3.

Non-T cell activation linker (NTAL) negatively regulates TREM-1/DAP12-induced inflammatory cytokine production in myeloid cells.

Tessarz AS, Weiler S, Zanzinger K, Angelisová P, Horejsí V, Cerwenka A.

J Immunol. 2007 Feb 15;178(4):1991-9.

4.

TREM-1 (triggering receptor expressed on myeloid cells): a new player in acute inflammatory responses.

Colonna M, Facchetti F.

J Infect Dis. 2003 Jun 15;187 Suppl 2:S397-401.

PMID:
12792857
5.

The TREM-1/DAP12 pathway.

Tessarz AS, Cerwenka A.

Immunol Lett. 2008 Mar 15;116(2):111-6. doi: 10.1016/j.imlet.2007.11.021. Epub 2007 Dec 26. Review.

PMID:
18192027
6.
7.

TREM-1 amplifies inflammation and is a crucial mediator of septic shock.

Bouchon A, Facchetti F, Weigand MA, Colonna M.

Nature. 2001 Apr 26;410(6832):1103-7.

PMID:
11323674
8.

FDF03, a novel inhibitory receptor of the immunoglobulin superfamily, is expressed by human dendritic and myeloid cells.

Fournier N, Chalus L, Durand I, Garcia E, Pin JJ, Churakova T, Patel S, Zlot C, Gorman D, Zurawski S, Abrams J, Bates EE, Garrone P.

J Immunol. 2000 Aug 1;165(3):1197-209.

9.
10.

Cutting edge: expression patterns of surface and soluble triggering receptor expressed on myeloid cells-1 in human endotoxemia.

Knapp S, Gibot S, de Vos A, Versteeg HH, Colonna M, van der Poll T.

J Immunol. 2004 Dec 15;173(12):7131-4.

11.

Cutting edge: inhibition of TLR and FcR responses in macrophages by triggering receptor expressed on myeloid cells (TREM)-2 and DAP12.

Hamerman JA, Jarjoura JR, Humphrey MB, Nakamura MC, Seaman WE, Lanier LL.

J Immunol. 2006 Aug 15;177(4):2051-5.

12.

Cutting edge: TREM-2 attenuates macrophage activation.

Turnbull IR, Gilfillan S, Cella M, Aoshi T, Miller M, Piccio L, Hernandez M, Colonna M.

J Immunol. 2006 Sep 15;177(6):3520-4.

13.
14.

TREM-1, MDL-1, and DAP12 expression is associated with a mature stage of myeloid development.

Gingras MC, Lapillonne H, Margolin JF.

Mol Immunol. 2002 Mar;38(11):817-24.

PMID:
11922939
15.

Triggering receptor expressed on myeloid cells-1 (TREM-1) amplifies the signals induced by the NACHT-LRR (NLR) pattern recognition receptors.

Netea MG, Azam T, Ferwerda G, Girardin SE, Kim SH, Dinarello CA.

J Leukoc Biol. 2006 Dec;80(6):1454-61. Epub 2006 Aug 29.

PMID:
16940328
16.
17.
18.

Btk is a positive regulator in the TREM-1/DAP12 signaling pathway.

Ormsby T, Schlecker E, Ferdin J, Tessarz AS, Angelisová P, Köprülü AD, Borte M, Warnatz K, Schulze I, Ellmeier W, Horejsí V, Cerwenka A.

Blood. 2011 Jul 28;118(4):936-45. doi: 10.1182/blood-2010-11-317016. Epub 2011 Jun 9.

19.

TREM-1 and DAP12 expression in monocytes of patients with severe psychiatric disorders. EGR3, ATF3 and PU.1 as important transcription factors.

Weigelt K, Carvalho LA, Drexhage RC, Wijkhuijs A, de Wit H, van Beveren NJ, Birkenhäger TK, Bergink V, Drexhage HA.

Brain Behav Immun. 2011 Aug;25(6):1162-9. doi: 10.1016/j.bbi.2011.03.006. Epub 2011 Mar 21.

PMID:
21421043

Supplemental Content

Support Center